VNA
CYTR

Valley National Advisers’s CytRx Corp CYTR Stock Holding History

Valley National Advisers’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-125
Closed – – 818
2019
Q1 		$0 Hold
125
– – ﹤0.01% 861
2018
Q4 		$0 Hold
125
– – ﹤0.01% 870
2018
Q3 		$0 Hold
125
– – ﹤0.01% 781
2018
Q2 		$0 Hold
125
– – ﹤0.01% 748
2018
Q1 		$0 Hold
125
– – ﹤0.01% 736
2017
Q4 		$0 Hold
125
– – ﹤0.01% 754
2017
Q3 		$0 Hold
125
– – ﹤0.01% 733
2017
Q2 		$0 Hold
125
– – ﹤0.01% 679
2017
Q1 		$0 Hold
125
– – ﹤0.01% 712
2016
Q4 		$0 Hold
125
– – ﹤0.01% 806
2016
Q3 		$0 Hold
125
– – ﹤0.01% 778
2016
Q2 		$2K Hold
125
– – ﹤0.01% 551
2016
Q1 		$2K Hold
125
– – ﹤0.01% 549
2015
Q4 		$2K Hold
125
– – ﹤0.01% 556
2015
Q3 		$2K Hold
125
– – ﹤0.01% 554
2015
Q2 		$3K Hold
125
– – ﹤0.01% 519
2015
Q1 		$3K Buy
+125
New +$2.33K ﹤0.01% 487

Other funds holding CYTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CTA
Colonial Trust Advisors Spartanburg, South Carolina $1.29B AUM 19.9% 1-Year Est. Return

Valley National Advisers's CYTR Position: Q2 2019 in Review

Valley National Advisers sold out of CytRx Corp (CYTR) in Q2 2019, closing a stake of 125 shares.

Valley National Advisers first reported a position in CYTR in Q1 2015 and held it in 17 quarters. The position peaked at $3K in Q2 2015. 5 funds tracked by Wall St. Rank hold CYTR as of Q2 2019.

  • Valley National Advisers reported no remaining CytRx Corp position as of Q2 2019 after selling out during the quarter.
  • Valley National Advisers sold 125 CytRx Corp shares in Q2 2019.
  • Valley National Advisers first reported a position in CytRx Corp in Q1 2015 and held it in 17 quarters.
  • Valley National Advisers's CytRx Corp position peaked at $3K in Q2 2015.
  • 5 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2019.

Based on Valley National Advisers's 13F filing for Q2 2019, filed 8 Aug 2019.